Recommendations for performing thromboelastography/thromboelastometry in hemophilia: communication from the SSC of the ISTH

被引:61
作者
Chitlur, M. [1 ]
Rivard, G. E. [2 ,3 ]
Lillicrap, D.
Mann, K. [4 ]
Shima, M. [5 ]
Young, G. [6 ]
机构
[1] Childrens Hosp Michigan, Detroit, MI 48201 USA
[2] CHU St Justine, Montreal, PQ, Canada
[3] Queens Univ, Kingston, ON, Canada
[4] Univ Vermont, Colchester, VT USA
[5] Nara Med Univ, Kashihara, Nara 634, Japan
[6] Univ So Calif, Childrens Hosp Los Angeles, Keck Sch Med, Los Angeles, CA 90027 USA
关键词
CALIBRATED AUTOMATED THROMBOGRAPHY; THROMBIN GENERATION; TISSUE FACTOR; WHOLE-BLOOD; CONTACT FACTOR; THROMBELASTOGRAPHY; ACTIVATION; THERAPY;
D O I
10.1111/jth.12458
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:103 / 106
页数:4
相关论文
共 12 条
[1]   Elimination of contact factor activation improves measurement of platelet-dependent thrombin generation by calibrated automated thrombography at low-concentration tissue factor [J].
Dargaud, Y ;
Luddington, R ;
Baglin, TP .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (05) :1160-1161
[2]   Quality and reliability of routine coagulation testing: can we trust that sample? [J].
Lippi, Giuseppe ;
Franchini, Massimo ;
Montagnana, Martina ;
Salvagno, Gian Luca ;
Poli, Giovanni ;
Guidi, Gian Cesare .
BLOOD COAGULATION & FIBRINOLYSIS, 2006, 17 (07) :513-519
[3]   Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition [J].
Luddington, R ;
Baglin, T .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (11) :1954-1959
[4]   Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery [J].
Riddell, Anne ;
Abdul-Kadir, Rezan ;
Pollard, Debra ;
Tuddenham, Edward ;
Gomez, Keith .
THROMBOSIS AND HAEMOSTASIS, 2011, 106 (03) :521-527
[5]   Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography [J].
Sorensen, B ;
Ingerslev, J .
HAEMOPHILIA, 2005, 11 :1-6
[6]   Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation [J].
Sorensen, B ;
Johansen, P ;
Christiansen, K ;
Woelke, M ;
Ingerslev, J .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (03) :551-558
[7]   Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A [J].
Sorensen, Benny ;
Persson, Egon ;
Ingerslev, Jorgen .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (02) :158-165
[8]   Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven®) therapy in haemophilia a patients [J].
Viuff, Dorthe ;
Andersen, Soren ;
Sorensen, Brit B. ;
Lethagen, Stefan .
THROMBOSIS RESEARCH, 2010, 126 (02) :144-149
[9]   Comparison of kaolin and tissue factor activated thromboelastography in haemophilia [J].
Young, G. ;
Zhang, R. ;
Miller, R. ;
Yassin, D. ;
Nugent, D. J. .
HAEMOPHILIA, 2010, 16 (03) :518-524
[10]   Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophofoa A and B patients with inhibitors:: a multicentre trial [J].
Young, Guy ;
Ebbesen, Liselotte S. ;
Viuff, Dorthe ;
Di Paola, Jorge ;
Konkle, Barbara A. ;
Negrier, Claude ;
Pasi, John ;
Ingerslev, Jorge .
BLOOD COAGULATION & FIBRINOLYSIS, 2008, 19 (04) :276-282